| Net income | 370.7M |
| Depreciation and amortization | 88.8M |
| Deferred income taxes | -3.1M |
| Stock-based compensation | 8M |
| Restructuring and impairment (credits) charges | -600K |
| Gain from sale of assets | 0 |
| Receivables | -179.5M |
| Inventories | -76.3M |
| Accounts payable, accrued expenses and other current liabilities | 33.1M |
| Other current assets | -10.3M |
| Increase Decrease In Current Operating Capital | -233M |
| Other items - net | -9M |
| Total operating activities | 221.8M |
| Capital expenditures | -139.2M |
| Acquisitions | -164.2M |
| Other items - net | 5M |
| Total investing activities | -298.4M |
| Dividends paid | -46.2M |
| Dividends paid to noncontrolling interests | -11.4M |
| Common shares purchased | 0 |
| Repayments of long-term debt | -100K |
| Other items - net | 13.6M |
| Total financing activities | -44.1M |
| Effect of exchange rate changes on cash | 17.9M |
| Net decrease in cash and cash equivalents | -102.8M |
| Cash and cash equivalents at the beginning of period | 896.2M |
| Cash and cash equivalents at the end of period | 793.4M |